Godellas N, Cymes G, Grosman C
Sci Adv. 2024; 10(48):eadq8048.
PMID: 39602532
PMC: 11601209.
DOI: 10.1126/sciadv.adq8048.
Godellas N, Cymes G, Grosman C
Proc Natl Acad Sci U S A. 2022; 119(44):e2204242119.
PMID: 36279466
PMC: 9636949.
DOI: 10.1073/pnas.2204242119.
Sanders V, Sweeney A, Topf M, Millar N
ACS Chem Neurosci. 2022; 13(12):1805-1817.
PMID: 35657695
PMC: 9204775.
DOI: 10.1021/acschemneuro.2c00200.
Godellas N, Grosman C
J Gen Physiol. 2022; 154(6).
PMID: 35612603
PMC: 9136306.
DOI: 10.1085/jgp.202213082.
Kassner M, Eaton J, Tang N, Petit J, Meurice N, Yin H
SLAS Discov. 2022; 27(1):68-76.
PMID: 35058178
PMC: 8816891.
DOI: 10.1016/j.slasd.2021.10.001.
Macroscopic and Microscopic Activation of 7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.
Quadri M, Garai S, Thakur G, Stokes C, Gulsevin A, Horenstein N
Mol Pharmacol. 2018; 95(1):43-61.
PMID: 30348894
PMC: 6277926.
DOI: 10.1124/mol.118.113340.
Mechanisms of neuroprotection against ischemic insult by stress-inducible phosphoprotein-1/prion protein complex.
Beraldo F, Ostapchenko V, Xu J, Di Guglielmo G, Fan J, Nicholls P
J Neurochem. 2017; 145(1):68-79.
PMID: 29265373
PMC: 7887631.
DOI: 10.1111/jnc.14281.
Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
Newcombe J, Chatzidaki A, Sheppard T, Topf M, Millar N
Mol Pharmacol. 2017; 93(2):128-140.
PMID: 29196491
PMC: 5767682.
DOI: 10.1124/mol.117.110551.
Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
Papke R, Stokes C, Damaj M, Thakur G, Manther K, Treinin M
Br J Pharmacol. 2017; 175(11):1838-1854.
PMID: 28477386
PMC: 5979752.
DOI: 10.1111/bph.13851.
Stoichiometry for α-bungarotoxin block of α7 acetylcholine receptors.
daCosta C, Free C, Sine S
Nat Commun. 2015; 6:8057.
PMID: 26282895
PMC: 4544739.
DOI: 10.1038/ncomms9057.
The influence of allosteric modulators and transmembrane mutations on desensitisation and activation of α7 nicotinic acetylcholine receptors.
Chatzidaki A, DOyley J, Gill-Thind J, Sheppard T, Millar N
Neuropharmacology. 2015; 97:75-85.
PMID: 25998276
PMC: 4548482.
DOI: 10.1016/j.neuropharm.2015.05.006.
Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
Gill-Thind J, Dhankher P, DOyley J, Sheppard T, Millar N
J Biol Chem. 2014; 290(6):3552-62.
PMID: 25516597
PMC: 4319022.
DOI: 10.1074/jbc.M114.619221.
An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin.
Frazier S, Cohen B, Lester H
J Biol Chem. 2013; 288(29):21029-21042.
PMID: 23720773
PMC: 3774370.
DOI: 10.1074/jbc.M112.423921.
Size matters in activation/inhibition of ligand-gated ion channels.
Du J, Dong H, Zhou H
Trends Pharmacol Sci. 2012; 33(9):482-93.
PMID: 22789930
PMC: 3427461.
DOI: 10.1016/j.tips.2012.06.005.
Changes in temperature have opposing effects on current amplitude in α7 and α4β2 nicotinic acetylcholine receptors.
Jindrichova M, Lansdell S, Millar N
PLoS One. 2012; 7(2):e32073.
PMID: 22359659
PMC: 3281115.
DOI: 10.1371/journal.pone.0032073.
Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
Williams D, Wang J, Papke R
Mol Pharmacol. 2011; 80(6):1013-32.
PMID: 21885620
PMC: 3228536.
DOI: 10.1124/mol.111.074302.
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.
Letchworth S, Whiteaker P
Biochem Pharmacol. 2011; 82(8):862-72.
PMID: 21736871
PMC: 3168519.
DOI: 10.1016/j.bcp.2011.06.022.
Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Gill J, Savolainen M, Young G, Zwart R, Sher E, Millar N
Proc Natl Acad Sci U S A. 2011; 108(14):5867-72.
PMID: 21436053
PMC: 3078348.
DOI: 10.1073/pnas.1017975108.
Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.
Sharma G, Vijayaraghavan S
Curr Med Chem. 2008; 15(28):2921-32.
PMID: 19075644
PMC: 2766171.
DOI: 10.2174/092986708786848703.
Thr339-to-serine substitution in rat P2X2 receptor second transmembrane domain causes constitutive opening and indicates a gating role for Lys308.
Cao L, Young M, Broomhead H, Fountain S, North R
J Neurosci. 2007; 27(47):12916-23.
PMID: 18032665
PMC: 6673282.
DOI: 10.1523/JNEUROSCI.4036-07.2007.